{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:16:10Z","timestamp":1771650970806,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","jenonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Emergency Nursing"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jen.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T17:44:56Z","timestamp":1570815896000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Deadly Trio: Heroin, FentaNYL, and Carfentanil"],"prefix":"10.1016","volume":"46","author":[{"given":"Deborah","family":"Salani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Mckay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zdanowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jen.2019.08.005_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/npp.2017.211","article-title":"Novel synthetic opioids and overdose deaths: tip of the iceberg?","volume":"43","author":"Baumann","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jen.2019.08.005_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jat\/bkx037","article-title":"Fatalities involving carfentanil and furanyl fentanyl: two case reports","volume":"41","author":"Swanson","year":"2017","journal-title":"J Anal Toxicol"},{"issue":"26","key":"10.1016\/j.jen.2019.08.005_bib6","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users - United States, 2002-2013","volume":"64","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"10.1016\/j.jen.2019.08.005_bib8","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increase in drug and opioid overdose deaths \u2013 United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jen.2019.08.005_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jen.2019.08.005_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jen.2019.08.005_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jcpt.12640","article-title":"The fentanyl family: a distinguished medical history tainted by abuse","volume":"43","author":"Raffa","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"10.1016\/j.jen.2019.08.005_bib13","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ajem.2017.02.043","article-title":"Fentanyl-laced heroin and its contribution to a spike in heroin overdose in Miami Dade County","volume":"35","author":"Bode","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.jen.2019.08.005_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/ajad.12230","article-title":"Reversal of overdose on fentanyl being illicitly sold as heroin with naloxone nasal spray: a case report","volume":"24","author":"Fareed","year":"2015","journal-title":"Am J Addict"},{"issue":"6","key":"10.1016\/j.jen.2019.08.005_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3928\/02793695-20160518-05","article-title":"Heroin use","volume":"54","author":"Salani","year":"2016","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"issue":"Pt A","key":"10.1016\/j.jen.2019.08.005_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jen.2019.08.005_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugpo.2018.08.004","article-title":"Being \u201chooked up\u201d during a sharp increase in the availability of illicitly manufactured fentanyl: adaptations of drug using practices among people who use drugs (PWUD) in New York City","volume":"60","author":"McKnight","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jen.2019.08.005_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2349-5014.184195","article-title":"Resurgence of fentanyl as a drug of abuse","volume":"2","author":"Tamburro","year":"2016","journal-title":"J Forensic Sci Med"},{"key":"10.1016\/j.jen.2019.08.005_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.forc.2017.02.003","article-title":"Analysis of illicit carfentanil: emergence of the death dragon","volume":"3","author":"Casale","year":"2017","journal-title":"Forensic Chem"},{"issue":"27","key":"10.1016\/j.jen.2019.08.005_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.15585\/mmwr.mm6727a4","article-title":"Notes from the field: overdose deaths with carfentanil and other fentanyl analogs detected -- 10 states, July 2016-June 2017","volume":"67","author":"O\u2019Donnell","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.jen.2019.08.005_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11419-017-0379-4","article-title":"Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil","volume":"36","author":"Misailidi","year":"2018","journal-title":"Forensic Toxicol"},{"key":"10.1016\/j.jen.2019.08.005_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and exogenous opioids in pain","volume":"41","author":"Corder","year":"2018","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"10.1016\/j.jen.2019.08.005_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clinic Proc"},{"issue":"4","key":"10.1016\/j.jen.2019.08.005_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/15563650.2016.1157722","article-title":"Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?","volume":"54","author":"Burns","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"8","key":"10.1016\/j.jen.2019.08.005_bib28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitory analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.jen.2019.08.005_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/ALN.0000000000000963","article-title":"Differential opioid tolerance and opioid-induced hyperalgesia: a clinical reality","volume":"124","author":"Hayhurst","year":"2016","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.jen.2019.08.005_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11065-007-9041-y","article-title":"Neuropsychological consequences of opiate use","volume":"17","author":"Gruber","year":"2007","journal-title":"Neuropsychol Rev"},{"issue":"10","key":"10.1016\/j.jen.2019.08.005_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/02699050210128915","article-title":"Impulse control differences between abstinent heroin users and matched controls","volume":"16","author":"Lee","year":"2002","journal-title":"Brain Inj"},{"issue":"Suppl 1","key":"10.1016\/j.jen.2019.08.005_bib32","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/pme.12926","article-title":"Opioid related endocrinopathy","volume":"16","author":"Guiden","year":"2015","journal-title":"Pain Med"},{"issue":"3 Suppl","key":"10.1016\/j.jen.2019.08.005_bib33","first-page":"ES145","article-title":"Opioid-induced androgen deficiency (OPIAD)","volume":"15","author":"Smith","year":"2012","journal-title":"Pain Phys"},{"issue":"43","key":"10.1016\/j.jen.2019.08.005_bib35","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths involving fentanyl, fentanyl analogs, and U-47700\u00a0\u221210 states, July-December 2016","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.jen.2019.08.005_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15585\/mm6604a4","article-title":"Multiple fentanyl overdoses \u2013 New Haven, Connecticut, June 23, 2016","volume":"66","author":"Tomassoni","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jen.2019.08.005_bib37","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment","author":"Comer","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"4, Suppl","key":"10.1016\/j.jen.2019.08.005_bib38","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.annemergmed.2017.07.281","article-title":"One-year mortality of opioid overdose victims who received naloxone by emergency medical services [abstract 402]","volume":"70","author":"Weiner","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.jen.2019.08.005_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s13181-017-0628-2","article-title":"ACMT and AACT position statement: preventing occupational fentanyl and fentanyl analog exposure to emergency responders","volume":"13","author":"Moss","year":"2017","journal-title":"J Med Toxicol"},{"issue":"2","key":"10.1016\/j.jen.2019.08.005_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsat.2006.08.002","article-title":"A comprehensive review of the psychometric properties of the Drug Abuse Screening Test","volume":"32","author":"Yudko","year":"2007","journal-title":"J Subst Abus Treat"},{"issue":"3","key":"10.1016\/j.jen.2019.08.005_bib43","first-page":"135","article-title":"Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice","volume":"94","author":"Brown","year":"1995","journal-title":"Wis Med J"},{"issue":"6","key":"10.1016\/j.jen.2019.08.005_bib44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.jen.2019.08.005_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jen.2016.09.004","article-title":"Epidemiology of opioid abuse and addiction","volume":"43","author":"Green","year":"2017","journal-title":"J Emerg Nurs"},{"issue":"16","key":"10.1016\/j.jen.2019.08.005_bib46","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department initiated buprenophine\/naloxone treatment for opioid dependence: a randomized trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jen.2019.08.005_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13722-017-0083-z","article-title":"Screening, treatment initiation, and referral for substance use disorders","volume":"12","author":"Berstein","year":"2017","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"10.1016\/j.jen.2019.08.005_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther Adv Drug Saf"}],"container-title":["Journal of Emergency Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0099176719304520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0099176719304520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:38:33Z","timestamp":1758829113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0099176719304520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0099176719304520"],"URL":"https:\/\/doi.org\/10.1016\/j.jen.2019.08.005","relation":{},"ISSN":["0099-1767"],"issn-type":[{"value":"0099-1767","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Deadly Trio: Heroin, FentaNYL, and Carfentanil","name":"articletitle","label":"Article Title"},{"value":"Journal of Emergency Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jen.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Emergency Nurses Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}